In Reply to Estimating GFR: The Devil Is in the Details

Research output: Contribution to journal › Comment/debate › Research › peer-review

Standard

In Reply to Estimating GFR : The Devil Is in the Details. / Iversen, Esben; Hornum, Mads; Houlind, Morten Baltzer.

In: American Journal of Kidney Diseases, Vol. 83, No. 2, 2024, p. 268-269.

Research output: Contribution to journal › Comment/debate › Research › peer-review

Harvard

Iversen, E, Hornum, M & Houlind, MB 2024, 'In Reply to Estimating GFR: The Devil Is in the Details', American Journal of Kidney Diseases, vol. 83, no. 2, pp. 268-269. https://doi.org/10.1053/j.ajkd.2023.10.006

APA

Iversen, E., Hornum, M., & Houlind, M. B. (2024). In Reply to Estimating GFR: The Devil Is in the Details. American Journal of Kidney Diseases, 83(2), 268-269. https://doi.org/10.1053/j.ajkd.2023.10.006

Vancouver

Iversen E, Hornum M, Houlind MB. In Reply to Estimating GFR: The Devil Is in the Details. American Journal of Kidney Diseases. 2024;83(2):268-269. https://doi.org/10.1053/j.ajkd.2023.10.006

Author

Iversen, Esben ; Hornum, Mads ; Houlind, Morten Baltzer. / In Reply to Estimating GFR : The Devil Is in the Details. In: American Journal of Kidney Diseases. 2024 ; Vol. 83, No. 2. pp. 268-269.

Bibtex

@article{580ef1ab312b4d8bb6bf300fa256c2f8,
title = "In Reply to Estimating GFR: The Devil Is in the Details",
author = "Esben Iversen and Mads Hornum and Houlind, {Morten Baltzer}",
note = "Funding Information: The authors declare that they have no relevant financial interests. Received October 16, 2023. Accepted October 31, 2023 after editorial review by an Associate Editor and a Deputy Editor.",
year = "2024",
doi = "10.1053/j.ajkd.2023.10.006",
language = "English",
volume = "83",
pages = "268--269",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B.Saunders Co.",
number = "2",

}

RIS

TY - JOUR

T1 - In Reply to Estimating GFR

T2 - The Devil Is in the Details

AU - Iversen, Esben

AU - Hornum, Mads

AU - Houlind, Morten Baltzer

N1 - Funding Information: The authors declare that they have no relevant financial interests. Received October 16, 2023. Accepted October 31, 2023 after editorial review by an Associate Editor and a Deputy Editor.

PY - 2024

Y1 - 2024

U2 - 10.1053/j.ajkd.2023.10.006

DO - 10.1053/j.ajkd.2023.10.006

M3 - Comment/debate

C2 - 37972815

AN - SCOPUS:85182197442

VL - 83

SP - 268

EP - 269

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 2

ER -

ID: 380215895